Courtney V Fletcher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Courtney V Fletcher

Showing results (81-90 of 162) with videos related to

Pageof 17

Sort By:

Antiviral Therapy|May 28, 2005

Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapyMarta Boffito, Edward Acosta, David Burger, et al.

The Lancet. Microbe|April 9, 2021

Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trialAndreas Diacon, Sachiko Miyahara, Rodney Dawson, et al.

The Journal of Antimicrobial Chemotherapy|July 27, 2021

Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c miceShetty Ravi Dyavar, Sushil Kumar, Nagsen Gautam, et al.

Antiviral Therapy|July 26, 2005

Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugsMarta Boffito, Edward Acosta, David Burger, et al.

Genes, Brain, and Behavior|August 3, 2020

Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian ratsShetty Ravi Dyavar, Lisa F Potts, Goichi Beck, et al.

AIDS (London, England)|May 26, 2011

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescentsJennifer J Kiser, Richard M Rutstein, Pearl Samson, et al.

Frontiers in Immunology|November 1, 2021

Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV InfectionOmalla A Olwenyi, Samuel D Johnson, Kabita Pandey, et al.

The Journal of Infectious Diseases|August 6, 2004

Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.

Clinical and Translational Science|September 20, 2019

Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot StudyEric S Daar, Marc I Rosen, Yan Wang, et al.

Journal of the Pediatric Infectious Diseases Society|April 23, 2016

Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.

Pageof 17

Search research articles

Showing results (81-90 of 162) with videos related to

Sort By:

Pageof 17

Antiviral Therapy|May 28, 2005

Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapyMarta Boffito, Edward Acosta, David Burger, et al.

The Lancet. Microbe|April 9, 2021

Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trialAndreas Diacon, Sachiko Miyahara, Rodney Dawson, et al.

The Journal of Antimicrobial Chemotherapy|July 27, 2021

Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c miceShetty Ravi Dyavar, Sushil Kumar, Nagsen Gautam, et al.

Antiviral Therapy|July 26, 2005

Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugsMarta Boffito, Edward Acosta, David Burger, et al.

Genes, Brain, and Behavior|August 3, 2020

Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian ratsShetty Ravi Dyavar, Lisa F Potts, Goichi Beck, et al.

AIDS (London, England)|May 26, 2011

Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescentsJennifer J Kiser, Richard M Rutstein, Pearl Samson, et al.

Frontiers in Immunology|November 1, 2021

Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV InfectionOmalla A Olwenyi, Samuel D Johnson, Kabita Pandey, et al.

The Journal of Infectious Diseases|August 6, 2004

Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjectsRonald Swanstrom, Ronald J Bosch, David Katzenstein, et al.

Clinical and Translational Science|September 20, 2019

Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot StudyEric S Daar, Marc I Rosen, Yan Wang, et al.

Journal of the Pediatric Infectious Diseases Society|April 23, 2016

Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.

Pageof 17